Format

Send to

Choose Destination
Am J Psychiatry. 1994 Aug;151(8):1234-6.

Amelioration of negative symptoms in schizophrenia by glycine.

Author information

1
Department of Psychiatry, Albert Einstein College of Medicine, Bronx Psychiatric Center, NY 10461.

Abstract

Phencyclidine induces a psychotomimetic state by blocking neurotransmission at N-methyl-D-aspartic acid (NMDA) receptors. In a double-blind, placebo-controlled fashion, 14 medicated patients with chronic schizophrenia were treated with glycine, a potentiator of NMDA-receptor-mediated neurotransmission. Significant improvement in negative symptoms occurred in the group given glycine but not in the group given placebo, suggesting that potentiation of NMDA-receptor-mediated neurotransmission may represent an effective treatment for neuroleptic-resistant negative symptoms in schizophrenia.

PMID:
8037263
DOI:
10.1176/ajp.151.8.1234
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center